[Combined medication ARTRA in the treatment of osteoarthrosis].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16404866)

Published in Ter Arkh on January 01, 2005

Authors

L I Alekseeva, N V Chichasova, L I Benevolenskaia, E L Nasonov, O I Mendel'

Articles citing this

Chondroitin for osteoarthritis. Cochrane Database Syst Rev (2015) 0.94

Articles by these authors

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96

[C-reactive protein--marker of inflammation in atherosclerosis (new data)]. Kardiologiia (2002) 0.88

[Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.87

Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis (2006) 0.83

[Neopterin: new immunological marker of autoimmune rheumatic disease]. Klin Med (Mosk) (2000) 0.83

[Cardiolipin antibodies in acute rheumatic fever]. Klin Med (Mosk) (1992) 0.82

[Evaluation of methotrexate effect on the acute-phase response in rheumatoid arthritis after 12-week treatment]. Klin Med (Mosk) (2014) 0.82

[Anti-phosphatidylethanolamine antibodies in patients with Sneddon's syndrome]. Klin Med (Mosk) (2005) 0.82

[The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results]. Ter Arkh (2012) 0.81

Soluble adhesion molecules in rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.81

[Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions]. Ter Arkh (2009) 0.80

[Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris]. Kardiologiia (1992) 0.80

[Cardiac rhythm and conduction disorders in polymyositis and dermatomyositis]. Klin Med (Mosk) (1998) 0.80

C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations. Artif Organs (1992) 0.80

[Relations between ankylosing spondyloarthritis and HLA-B27 in various ethnic groups in Russia]. Ter Arkh (2001) 0.80

[Effect of small-dose glucocorticoids on the course of early rheumatic arthritis]. Klin Med (Mosk) (2004) 0.79

[Some infectious (streptococcal) and genetic aspects of familial rheumatic fever]. Vopr Revm (1974) 0.78

[Structum (chondroitin sulfate)--a new agent for the treatment of osteoarthrosis]. Ter Arkh (1999) 0.78

[Role of heredity and environment in rheumatism]. Vopr Revm (1980) 0.78

[New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. Ter Arkh (2010) 0.78

[Serum neopterin in hepatitis B]. Klin Med (Mosk) (1992) 0.78

[Results of the multicenter clinical trial of structum preparation in Russia]. Ter Arkh (2001) 0.78

[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]. Ter Arkh (2009) 0.77

[The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis]. Klin Med (Mosk) (2014) 0.77

[The von Willebrand factor antigen in patients with rheumatoid arthritis: a method for its determination and the clinical significance]. Ter Arkh (1993) 0.77

[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77

[Issues of osteoporosis in present-day medicine]. Vestn Ross Akad Med Nauk (2003) 0.77

[Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2004) 0.77

[Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial]. Ter Arkh (2005) 0.77

[Cardiovascular diseases in rheumatoid arthritis]. Ter Arkh (2007) 0.77

[The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis]. Ter Arkh (2013) 0.77

[Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis]. Ter Arkh (2013) 0.77

[Prospects for the assessment of cardiac rhythm variability in patients with rheumatoid arthritis and systemic lupus erythematosus]. Vestn Ross Akad Med Nauk (2010) 0.77

[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77

[The prevalence of rheumatoid arthritis and the rheumatoid factor in the native inhabitants of northeastern Siberia]. Ter Arkh (1999) 0.77

[Sneddon's syndrome and the primary antiphospholipid syndrome]. Ter Arkh (1993) 0.76

Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol (1991) 0.76

[The epidemiology of spondyloarthropathies among the native inhabitants of Chukotka. 2. The prevalence of HLA-B27 in the population and among spondyloarthropathy patients]. Ter Arkh (1994) 0.76

[Autoantibodies Against beta(1)-Adrenoreceptors in Patients With Cardiac Rhythm Disorders. Prevalence and Possible Role in Development of Arrhythmia]. Kardiologiia (2004) 0.76

[Soluble receptors of TNF-alpha with molecular mass 55 kDa in rheumatoid arthritis: clinical role]. Klin Med (Mosk) (2003) 0.76

[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76

[Evaluation of the efficacy and tolerance of ibandronic acid in patients with osteoarthrosis in the knee joints concurrent with osteoporosis: a pilot study]. Ter Arkh (2013) 0.76

[The clinical significance of neopterin in human diseases]. Ter Arkh (1993) 0.76

[Soluble receptors of TNF-alpha in rheumatoid arthritis]. Klin Med (Mosk) (2001) 0.76

[The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Ter Arkh (1989) 0.76

Anticardiolipin antibodies in Sneddon's syndrome. Neurology (1990) 0.76

[Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis]. Ter Arkh (1999) 0.76

[Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2006) 0.76

[Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Ter Arkh (2008) 0.76

[Cognitive impairment and anxiety-depressive disorders in patients with rheumatoid arthritis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.76

[Osteoarthritis and cardiovascular diseases in elderly patients: clinical and pathogenetic interrelationship]. Adv Gerontol (2010) 0.76

[Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type]. Ter Arkh (2012) 0.76

[Pharmacotherapy of rheumatoid arthritis: the 21st century]. Klin Med (Mosk) (2005) 0.75

[Rheumatism in the Russian Federation: statistic and reality]. Vestn Ross Akad Med Nauk (1996) 0.75

[The renin-angiotensin-aldosterone system and arterial hypertension in patients with rheumatoid arthritis]. Klin Med (Mosk) (1991) 0.75

[Long-term effects of structum administration (according to data from multicenter trial)]. Ter Arkh (2003) 0.75

[The role of hereditary factors in the development of psoriatic arthritis and the nature of its interrelations with psoriasis]. Ter Arkh (1988) 0.75

[Elaboration of diagnostic criteria for rheumatism suitable for epidemiologic research]. Vopr Revm (1972) 0.75

[The genetics of rheumatic diseases: genetic basis of the classification of multifactorial diseases]. Vestn Akad Med Nauk SSSR (1989) 0.75

[Population genetics study of rheumatism in the Dolgans of the Taimyr]. Genetika (1981) 0.75

[Distribution of type-specific antibodies to streptococcal lipoproteinase based on population screening data]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75

[A clinico-epidemiologic study of familial rheumatism]. Vopr Revm (1972) 0.75

[On the organization of rheumatism control in children in Czechoslovakia]. Pediatriia (1967) 0.75

[A comparative test of Soviet and American diagnostic criteria for osteoarthrosis (gonarthrosis)]. Revmatologiia (Mosk) (1990) 0.75

[Study of the association of histocompatibility antigens with rheumatism]. Ter Arkh (1986) 0.75

[Current achievements in the study of genetic aspects of rheumatic diseases]. Vestn Akad Med Nauk SSSR (1986) 0.75

[DNA typing of HLA class II genes among the aboriginal inhabitants of Chukotka]. Genetika (1995) 0.75

[Directed cloning of the HLA-B27 gene isolated from a patient with ankylosing spondylitis (Bechterew's disease)]. Mol Gen Mikrobiol Virusol (1990) 0.75

[Clinical significance of antibodies to the smooth musculature in chronic active hepatitis]. Klin Med (Mosk) (1980) 0.75

[Hepatitis B surface antigen in chronic active hepatitis and primary biliary cirrhosis]. Sov Med (1978) 0.75

[Occurrence of rheumatic fever and streptococcal infection in the population of the Todzhinsk Region of the Tuva ASSR]. Vopr Revm (1982) 0.75

[First results of developing diagnostic criteria for rheumatism suitable for epidemiological research]. Vopr Revm (1974) 0.75

[Clinico-genetic associations in systemic lupus erythematosus]. Ter Arkh (1981) 0.75

[Incidence of rheumatism among the Taimyr population and the role of environmental factors]. Vopr Revm (1981) 0.75

[Prevalence of osteoarthrosis in the population]. Ter Arkh (1987) 0.75

[Prevention of rheumatism in children within a district]. Med Sestra (1968) 0.75

[Hyperuricemia, gout and gout-induced nephropathy]. Ter Arkh (1980) 0.75

[Spondylarthritis ankylopoietica and HLA-B27]. Ter Arkh (1992) 0.75

[Type of inheritance of rheumatism and rheumatoid arthritis]. Vopr Revm (1979) 0.75

[Clinico-pathogenetic factors in the development of immune complex disease]. Ter Arkh (1980) 0.75

[Problem of diagnostic criteria in rheumatism]. Revmatologiia (Mosk) (1991) 0.75

[Circulating immune complexes in rheumatic diseases]. Ter Arkh (1981) 0.75

[A methodology for studying risk factors in rheumatic diseases]. Klin Med (Mosk) (1989) 0.75

[Various genetic aspects of systemic lupus erythematosus]. Revmatologiia (Mosk) (1988) 0.75

[Aspects of the methodology of epidemiological research]. Vopr Revm (1979) 0.75

[Gerontological and geriatric problems of nephrology]. Ter Arkh (1981) 0.75

[Role of the immunofluorescence technic in diagnosis of chronic liver diseases]. Ter Arkh (1978) 0.75

[Significance of the degree of activity during the rheumatic process in children with mitral stenosis]. Vopr Okhr Materin Det (1968) 0.75

[HLA antigens in juvenile rheumatoid arthritis]. Revmatologiia (Mosk) (1991) 0.75

[DNA typing of allelic variants of HLA-B27: HLA-B*2705 is the predominant allele of the aboriginal population of the Chukot peninsula (Eskimos and Chukchi)]. Mol Gen Mikrobiol Virusol (1995) 0.75

[Various genetic aspects of Bechterew's disease]. Ter Arkh (1980) 0.75

[Factors promoting development of osteoarthrosis]. Ter Arkh (1987) 0.75